The polymorphisms in the MT-RNR1 and MT-RNR2 genes were associated with increased mitochondrial and clinical adverse effects, most commonly ototoxicity and peripheral neuropathy [54, 68]. Here, MT-RNR1 is linked to ototoxicity.